NasdaqCM - Nasdaq Real Time Price USD
BioLife Solutions, Inc. (BLFS)
Tune into earnings calls Now streaming directly on quote pages.
24.01
+1.65
+(7.40%)
As of 2:37:09 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.02 | 0 | -0.03 | 0.17 |
| Low Estimate | -0.02 | 0 | -0.07 | 0.16 |
| High Estimate | -0.01 | 0.01 | 0 | 0.18 |
| Year Ago EPS | -0.05 | -0.02 | -0.06 | -0.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 7 |
| Avg. Estimate | 23.52M | 24.84M | 97.75M | 115.34M |
| Low Estimate | 22.8M | 24.2M | 97.2M | 112M |
| High Estimate | 24.2M | 25.95M | 98M | 120.4M |
| Year Ago Sales | 28.33M | 30.57M | 82.25M | 97.75M |
| Sales Growth (year/est) | -16.97% | -18.76% | 18.84% | 18.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.05 | -0.06 | -0.04 |
| EPS Actual | -0.05 | -0.02 | -0.02 | 0.04 |
| Difference | 0.04 | 0.03 | 0.04 | 0.07 |
| Surprise % | 45.68% | 62.50% | 71.77% | 201.43% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.02 | 0 | -0.03 | 0.17 |
| 7 Days Ago | -0.01 | 0 | -0.03 | 0.15 |
| 30 Days Ago | -0.01 | 0 | -0.03 | 0.15 |
| 60 Days Ago | -0.01 | 0 | -0.03 | 0.15 |
| 90 Days Ago | -0.03 | -0.01 | 0.01 | 0.28 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 3 | 1 |
| Up Last 30 Days | 2 | 2 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLFS | 67.12% | 119.03% | 48.41% | 610.05% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
| Maintains | Northland Capital Markets: Outperform to Outperform | 1/8/2025 |
| Reiterates | Benchmark: Buy to Buy | 12/19/2024 |
| Maintains | Keybanc: Overweight to Overweight | 12/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
| Maintains | TD Cowen: Buy to Buy | 11/13/2024 |
Related Tickers
ATRC AtriCure, Inc.
30.89
-0.93%
AZTA Azenta, Inc.
27.21
-1.82%
DIM.PA Sartorius Stedim Biotech S.A.
202.50
-0.30%
AVR Anteris Technologies Global Corp.
4.2950
-1.94%
TCHBF Tecan Group AG
182.45
0.00%
AVTR Avantor, Inc.
12.14
-1.14%
ANGO AngioDynamics, Inc.
9.15
-1.40%
CUPR Cuprina Holdings (Cayman) Limited
4.6615
+3.13%
FIE.DE Fielmann Group AG
54.00
+1.89%
RGEN Repligen Corporation
124.52
-2.61%